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Available online 14 December 2016Background: Previous large population studies reported that non-fasting plasma triglyceride (TG) reﬂect a higher
risk for cardiovascular disease than TG in the fasting plasma. This is suggestive of the presence of higher concen-
tration of remnant lipoproteins (RLP) in postprandial plasma.
Methods: TG and RLP-TG together with other lipids, lipoproteins and lipoprotein lipase (LPL) in both fasting and
postprandial plasma were determined in generally healthy volunteers and in patients with coronary artery dis-
ease (CAD) after consuming a fat load or a more typical moderate meal.
Results: RLP-TG/TG ratio (concentration) and RLP-TG/RLP-C ratio (particle size) were signiﬁcantly increased in
the postprandial plasma of both healthy controls and CAD patients compared with those in fasting plasma.
LPL/RLP-TG ratio demonstrated the interaction correlation between RLP concentration and LPL activity The in-
creased RLP-TG after fat consumption contributed to approximately 90% of the increased plasma TG, while ap-
proximately 60% after a typical meal. Plasma LPL in postprandial plasma was not signiﬁcantly altered after
either type of meal.
Conclusions: Concentrations of RLP-TG found in the TG along with its particle size are signiﬁcantly increased in
postprandial plasma compared with fasting plasma. Therefore, non-fasting TG determination better reﬂects
the presence of higher RLP concentrations in plasma.Labora
achi, M
.
. This i© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Keywords:
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Food intake (fat load)1. Introduction
Zilversmit ﬁrst proposed the postprandial increase of TG to be the
most common form of hyperlipidemia which is associated with in-
creased remnant lipoproteins (RLP) as a risk factor for cardiovascular
disease (CVD) [1]. More recently, Nordestgaard et al. [2], Bansal et al.
[3] and Iso et al. [4] reported that the triglycerides (TG) measured in
non-fasting samples were more sensitive than the conventional mea-
surements of the fasting TG concentrations in predicting the risk of car-
diovascular events (the Copenhagen Heart Study, Women's Health
Study and the Japanese population study). Also, the Framingham Off-
spring Study previously reported by us [5] showed that the fasting TGtory Medicine, Gunma
aebashi, Gunma, Japan.
s an open access article underconcentration was not an independent cardiovascular risk factor,
while RLP-cholesterol (RLP-C) was an independent risk factor in the
fasting plasma in women. Therefore, it is necessary to investigate the
difference between fasting and postprandial TG and RLP: why does
the postprandial TG indicate greater risk than the fasting TG concentra-
tion? It has been shown that postprandial TG is associated with in-
creased remnants of apoB-48 carrying chylomicrons (CM) of intestinal
origin and apoB-100 carrying very low density lipoproteins (VLDL) of
hepatic origin in the postprandial state [6]. Postprandial TG and RLP
are known to attain their highest concentrations 3–6 h after food intake
[7–9]. Therefore, we analyzed the RLP-TG/TG ratio (concentration) and
RLP-TG/RLP-C ratio (particle size) [10] associated with the lipoprotein
lipase (LPL) activity and concentration in both the fasting and postpran-
dial plasma. However, the deﬁnition of RLP has been unclear for many
years, in part due to the variety of methods used to measure RLP. The
most common deﬁnition of RLP proposed several decades ago is basedthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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centrifugation method [11]. As the most important characteristic of
RLP has been shown to be the TG-rich lipoproteins that are increased
after food intake [1], IDL cannot be utilized as indicative RLP, since IDL
does not signiﬁcantly increase following food intake [12–14]. There
are other methods, such as electrophoresis, NMR and HPLC, that are
used to identify RLP by charge, particle size [15] and the calculated rem-
nant cholesterol [16], respectively, but none isolate a substantial RLP
particle.
We reported the isolationmethod of RLP by immunoafﬁnity gels and
its diagnostic utility in serum and plasma as RLP-C and RLP-TG over the
decades [17–20]. Therefore, we were able to perform a direct compari-
son between the increased total TG and isolated RLP-TG in the fasting
and postprandial plasma. We have already reported that the increase
of RLP-TG (postprandial RLP-TG minus fasting RLP-TG) comprises ap-
proximately 80% of the increased TG (postprandial TG minus fasting
TG) when a fat rich meal or high fat cream is ingested [21].
In this study, we report plasma concentrations of TG and RLP-TG
in the fasting and postprandial plasma in normal controls as well as
patients with CVD who consumed typical moderate meals in the
course of daily life and also the results with studies using a fat load.
In order to investigate the characteristics of increased TG in the
postprandial plasma, the measurement of the TG in RLP (RLP-TG),
rather than RLP-C, was the primary focus of this study. As we
demonstrated that the majority of plasma LPL circulating in plasma
is bound to RLP [22], we compared the RLP-TG/TG, RLP particle size
and LPL concentration in healthy controls and CAD patients. Also
we newly calculated the LPL/RLP-TG ratio as Felts et al. [23]
demonstrated as LPL/TG for the interaction correlation between
remnant concentration and LPL activity. Finally, we discussed the
mechanism of the increase in RLP-TG and delayed clearance of RLP
that occurs after food intake, which is closely associated with LPL
activity and concentration on endothelial cells and release into
circulation.2. Materials and methods
2.1. Fifty four Japanese volunteers who were without evidence of CVD, dia-
betes or other chronic disease (30 males and 24 females, aged 28–63 y)
were recruited for the oral fat load test at the Gunma University School of
Health Sciences (Table 1)
The study was approved by the Ethics Committee of Gunma Univer-
sity School of Medicine and all of the volunteers provided written in-
formed consent to participate in this study. Brieﬂy, after an overnight
12 h fast, the subjects ingested 17 g/m2 (body surface area) of fat emul-
sion (OFTT cream, Jomo Foods) [7]. Blood samples were taken before
and 60, 120, 240 and 360 min after the oral fat load.Table 1
The changes of plasma lipids, lipoproteins and LPL concentration after fat load; oral fat load in
0 h 2 h
Median (25%–75% tile) Median (25%–75
TC (mg/dl) 225 (184–250) 230 (180–260)
TG (mg/dl) 113 (66–160) 140 (110−220)
HDL-C (mg/dl) 67 (45–80) 70 (40–80)
LDL-C (mg/dl) 128 (105–150) 130 (100–150)
RLP-C (mg/dl) 5.6 (3.9–6.9) 6.3 (4.9–8.4)⁎
RLP-TG (mg/dl) 13.8 (5.5–29.3) 37.7 (35.4–68.4)
RLP-TG/RLP-C 2.1 (1.3–4.9) 7.2 (5.7–8.5)⁎
RLP-TG/TG 0.11 (0.08–0.19) 0.32 (0.27–0.34)
apoB-100 (mg/dl) 111.9 (88.8–162.4) 126.4 (87.7–173
apoB-48 (μg/ml) 6 (3.1–10.3) 10.8 (6.3–14)⁎
LPL (ng/ml) 23.7 (19.4–25.7) 23 (18.8–28.0)
LPL/RLP-TG 1.92 (0.9–4.4) 0.5 (0.38–0.75)⁎
⁎ means P b 0.05.2.2. The comparison study in fasting and postprandial plasma was per-
formed on samples obtained from relatively healthy young (40 males and
39 females) subjects (Caucasian 45, Asian 10, Hispanic 9, African American
7, others 8) recruited at the University of California, Davis, CA (Table 2)
Some of the subjects were overweight or obesewith amedian age of
24 y and a median BMI of 24 kg/m2. Inclusion criteria included an age
from 18 to 40 y and BMI of 18–35 kg/m2 with a self-report of stable
body weight during the prior 6 months. All seventy nine volunteers
were injected with heparin (50 unit/kg) for the LPL and HTGL activity
assays. The University of California at Davis Institutional Review Board
approved the experimental protocol and all of the subjects provided
written informed consent to participate in the study. Baseline blood
samples from this study of the metabolic effects of dietary sugars were
used and were obtained by the method of Stanhope et al. [24] and all
of the parameter analyses were performed at Gunma University. The
fasting blood samples were collected before breakfast at between
08:00 and 09:00 h and the postprandial blood samples were collected
several hours after the dinner meal between 20:00 and 22:00 h on the
same day. During the day, standardized meals [25] were provided as
breakfast, lunch and dinner to all of the subjects.
2.3. A case control study of RLP-C and RLP-TG concentrations in patients
with angiographically determined coronary artery disease (CAD) and
healthy controls was performed
This is a part of the study previously reported by Leary et al. [26] to
establish US reference ranges for the serum RLP-C concentrations.
Men and women N17 y were recruited in 4 different parts of the USA
(Austin, TX; Brighton, MA; Miami, FL; and Phoenix, AZ). These subjects
were free of symptoms and any signs of CAD and also of any endocrine
or metabolic disorders that might affect lipid metabolism. However, the
lipid and lipoprotein concentrations per se were not part of the inclu-
sion or exclusion criteria. None of the subjects were taking any medica-
tion expected to alter lipid or lipoprotein metabolism. Each subject was
asked to participate in 2 visits: 1 after 12 h of fasting and 1 at a random
time in relation to the last meal (either fasting or non-fasting). The ran-
dom sample was considered to be in the postprandial state for this
study. Serum concentration of RLP-C, RLP-TG, total cholesterol (TC),
TG, LDL-C and HDL-C were measured at each visit. To evaluate the rela-
tive CAD risk of RLP-C and RLP-TG in predicting CAD, 203 adult patients
with N20% stenosis of at least one coronary artery at the time of coro-
nary angiography were recruited from nine medical centers in the
USA and one medical center in Canada. Control subjects (n = 477)
with similar ages to the CAD patients were recruited from the same 4
US centers that participated in the reference range study. Subjects
with serum TG blank values N50 mg/dl (because of the heparin used
during angiography before specimen collection), who did not complete
both visits, or who did not have a fasting specimen collected werehealthy Japanese controls.
4 h 6 h
% tile) Median (25%–75% tile) Median (25%–75% tile)
230 (180–250) 230 (180–260)
⁎ 180 (140–380)⁎ 160 (80–300)⁎
70 (40–80) 70 (40–80)
130 (100–140) 130 (100–150)
8.1 (5.4–13.8)⁎ 7.5 (4.7–20)⁎
⁎ 86.2 (38.4–224.4)⁎ 77.7 (16.3–142.4)⁎
11.6 (6.4–15.9)⁎ 5.6 (3.4–11.4)⁎
⁎ 0.47 (0.31–0.59)⁎ 0.36 (0.19–0.55)⁎
) 126.2 (95–160.2) 126.6 (101–168.3)
13 (6.4–18.3)⁎ 9.3 (3.8–22.8)⁎
20.6 (18.0–23.0) 22.2 (16.9–25.9)
0.48 (0.22–0.8)⁎ 0.65 (0.13–1.32)
Table 2
Characteristics of lipids, lipoproteins and lipases in the fasting and postprandial state in
post-heparin plasma; effect of standard meal assessments in Americans.
Fasting (n = 79) Postprandial (n = 79) p
Median (25% tile–75%
tile)
Median (25% tile–75%
tile)
TC (mg/dl) 160 (141–182) 160 (145–184) n.s.
TG (mg/dl) 47 (31–74) 73 (44–106) p b 0.001
HDL-C (mg/dl) 47 (41–59) 47 (40–58) n.s.
LDL-C (mg/dl) 90 (70–107) 91 (73–108) n.s.
sd-LDL (mg/dl) 21.4 (16.9–31.0) 24.4 (18.7–36) n.s.
RLP-C (mg/dl) 3.5 (2.5–4.8) 4.7 (3.5–6.8) p b 0.001
RLP-TG (mg/dl) 4.2 (2.3–7.3) 14.6 (8.0–28.5) p b 0.001
RLP-TG/RLP-C 1.4 (0.7–2.0) 3.6 (1.9–5.3) p b 0.001
RLP-TG/TG 0.09 (0.06–0.11) 0.23 (0.15–0.30) p b 0.001
LPL (U/l) 79 (68.5–89.3) 66 (57.0–78.6) p b 0.001
LPL (ng/ml) 206.4 (176.9–250.9) 205.5 (175.7–237.8) n.s.
LPL (U/l)/RLP-TG 19.6 (10.4–34.0) 4.4 (2.2–8.9) p b 0.001
LPL
(ng/ml)/RLP-TG
56.5 (26.9–98.5) 12.5 (7.2–28.0) p b 0.001
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patients and 301 controls based on the inclusion and exclusion criteria.
All clinical protocols were approved by the Institutional Review Board,
and informed consent formswere signed by all of the participating sub-
jects. All sampleswere sent to Paciﬁc Biometrics, Inc., a commercial spe-
cialty lipid laboratory in Seattle, WA accredited by the College of
American Pathologists, for analysis of the lipids and lipoproteins.2.4. Measurements of lipids and lipoproteins and LPL and HTGL activity/
concentration
The plasma samples for themeasurement of TC, TG, HDL-C, LDL-C,
RLP-C, RLP-TG and sdLDL-C were obtained before and after heparin
infusion and kept frozen at −80 °C until analysis. As LPL and HTGL
activities were not detectable in the pre-heparin plasma, all the li-
pase activities in this studywere determined in post-heparin plasma.
The post-heparin plasma sample was collected 15 min after the in-
travenous injection of 50 units of heparin/kg body weight (BW) for
the assay of the LPL/HTGL activity and concentration. Pre-heparin
LPL and HTGL concentrationwere determinedwith a highly sensitive
and speciﬁc ELISA [27,28]. LPL and HTGL activity was analyzed by the
Imamura method [29]. TC and TG concentration were determined
enzymatically. LDL-C and HDL-C concentrations were measured
using a homogenous method (Kyowa Medex). Glucose and insulin
were determined by PolyChem (Polymedco). RLP-C and RLP-TG
were determined using an immunoseparation method (JIMRO II)
[18]. Small dense LDL-C was determined by the method of Ito et al.
(Denka-Seiken) [30].Fig. 1. The changes of plasma TG and RLP-TG concentrat2.5. Statistics
All values were expressed as the median and the 25th and 75th per-
centiles. Data were analyzed with Stat Flex version 5.0 for Windows
(Artec). The statistical signiﬁcance of differences was determined by
Wilcoxon test for two-group comparison and Kruskal-Wallis test and
then multiple comparison tests for non-parametric analysis and Dunn
test for multi-group comparisons. The comparison between the healthy
control group and CAD group conducted byMann-Whitney'sU test. The
correlation between variables is presented as Pearson's correlation coef-
ﬁcient (r value). A p b 0.05 was considered statistically signiﬁcant.
3. Results
3.1. Effect of oral fat load on lipids, lipoproteins and the LPL concentration in
plasma
Serum TG concentrations increased 1.6-fold 4 h after the fat load,
while RLP-TG increased 6.2-fold, as shown in Table 1. Therefore, the
RLP-TG/TG ratio increased signiﬁcantly from 0.11 (0 h) to 0.47 in a 4 h
period (4.3-fold). The increase in RLP-C in the postprandial plasma
was 1.5 fold and the RLP-C/TG ratio was 5.0% in the fasting plasma
and was decreased slightly at 4 h (4.5%) in the postprandial plasma.
The RLP-TG/RLP-C ratio, which reﬂects the RLP particle size [10] was in-
creased 5.5-fold 4 h after the fat load, which means that the RLP parti-
cles became signiﬁcantly larger (i.e., more TG-rich) than the fasting
RLP particles. Fig. 1 shows the changes in the RLP-TG/TG ratio from be-
fore the fat load (y = 0.230x − 8.1) to 4 h after the fat load (y =
0.677x− 33.8), indicating a more than two fold increase of RLP-TG in
the total TG. Fig. 2 shows the changes of the plasma delta TG concentra-
tion (the postprandial TG minus the fasting TG) and delta RLP-TG (the
postprandial RLP-TG minus the fasting RLP-TG) at 2, 4 and 6 h after
the fat load. Signiﬁcantly higher RLP-TG content was found in the
delta TG concentration, approximately 90% of which is comprised of
the increased TG (delta TG) after the fat load and which kept increasing
for 2 to 6 h in the postprandial plasma. However, the LPL concentration
did not increase in association with the increase in TG and RLP-TG after
the fat load (Table 1). Therefore, the LPL/RLP-TG ratio was highest be-
fore the fat load and decreased to approximately 1/4 of that after the
fat load. Those results show that the large RLP particles after a fat load
carry signiﬁcantly low LPL concentration (p b 0.001) compared with
the small RLP particles in the fasting plasma.
3.2. Effect of a standard meal on TG and RLP-TG in healthy subjects
Fasting and postprandial plasma concentrations of lipids and lipo-
proteins as well as the LPL and HTGL activity and concentration in the
post-heparin plasma in 79 volunteers are shown in Table 2. Themedian
TC, LDL-C, sdLDL-C and HDL-C concentrations were within the normalion and ratio before and 2, 4, and 6 h after fat load.
Fig. 2. The changes (delta) of plasma TG and delta RLP-TG concentration in 2 h, 4 h, and 6 h after fat load.
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(8 PM) plasma. TG, RLP-C, RLP-TG, RLP-TG/RLP-C and RLP-TG/TG were
signiﬁcantly increased in the postprandial state in the post-heparin
plasma. LPL activity and concentration were slightly decreased in post-
prandial plasma comparedwith fasting plasma followed by signiﬁcantly
increased TG and RLP-TG (Table 2). Therefore, LPL/RLP-TG ratiowas sig-
niﬁcantly higher in fasting than in postprandial plasma anddecreased to
less than 1/4 of that in postprandial plasma. Those results show that the
large RLP particles in postprandial plasma carry signiﬁcantly low
amount of LPL (p b 0.001) compared with the small RLP particles in
the fasting plasma. Those results showed the same phenomena after
fat load. HTGL activity and concentration were unchanged in the post-
prandial plasma (data not shown).
A signiﬁcantly higher RLP-TG/TG ratio (p b 0.001) was observed in
the postprandial plasma (y= 0.501x− 12.3) than in the fasting plasma
(y = 0.281x− 10.7) (Fig. 3) and showed the difference of correlation
between TG and RLP-TG in fasting (r = 0.77) and postprandial plasma
(r = 0.93). The increase of RLP-TG (delta RLP-TG) contributed to ap-
proximately 60% of the TG increase (delta TG) after the standard meal
and these were highly correlated (r= 0.92; p b 0.001; Fig. 3). These re-
sults show that postprandial TG contained a signiﬁcantly higher concen-
tration of RLP-TG than was measured in the fasting plasma samples.
3.3. Case control study of RLP-C and RLP-TG concentration in patients with
angiographically determined CAD and healthy control subjects
Table 3 shows that RLP-C, RLP-TG, RLP-TG/RLP-C and RLP-TG/TG
were all signiﬁcantly increased in postprandial (random) plasma com-
pared with fasting plasma in both healthy control subjects and CADFig. 3. The correlation between plasma TG and RLP-TG concentration in the faspatients. A signiﬁcant difference in RLP-C (p b 0.05) was observed be-
tween the controls and CAD patients in fasting plasma, while no signif-
icant difference in RLP-TG was found between the controls and CAD
patients in either fasting or postprandial (random) plasma.
Fig. 4 shows that a signiﬁcantly higher RLP-TG/TG ratio (p b 0.001)
was observed in postprandial (random) plasma (y = 0.404x− 23.6)
than in fasting plasma (y= 0.282x− 13.9) in the controls. The increase
in RLP-TG (delta RLP-TG) contributed to approximately 60% of the TG
increase (delta TG) after the regular meal and the correlation between
these two increased (r = 0.85; p b 0.001). However, a similar RLP-TG/
TG ratio was observed in postprandial (random) plasma (y =
0.481x− 37.7) and fasting plasma (y= 0.422x− 35.7) in CAD patients
(Fig. 5). The differences in the TG and RLP-TG correlation in fasting and
postprandial (random) plasma was signiﬁcant in CAD patients
(p b 0.001). The increase in RLP-TG (delta RLP-TG) contributed to ap-
proximately 60% of the TG increase (delta TG) and these two increase
was highly correlated (r = 0.83; p b 0.01). Fig. 6 shows that the RLP-
TG/TG ratio was signiﬁcantly higher (p b 0.001) in postprandial (ran-
dom) plasma than fasting plasma in both the normal controls and
CAD patients.
4. Discussion
We reported that RLP is approximately 1/3 comprised of VLDL
(d b 1.006) in the fasting plasma and its ratio changes depending on
the physiological conditions [31]. Although our previous studies were
mostly focused on the cholesterol content in RLP as RLP-C, a major
RLP component is RLP-TG, not RLP-C. The plasma TG concentration is
known to reﬂect the total VLDL as a surrogatemarker in both the fastingting and postprandial plasma and between the delta TG and delta RLP-TG.
Table 3
Plasma lipid and lipoprotein concentration in the healthy controls and the cases with coronary artery disease; comparison between CAD cases vs. controls.
Control (n = 302) CAD (n = 151) p
A. Fasting B. Random C. Fasting D. Random A vs. B C vs. D A vs. C B vs. D
Median (25% tile–75%
tile)
Median (25% tile–75%
tile)
Median (25% tile–75%
tile)
Median (25% tile–75%
tile)
Age 53 (62–69) 50 (58–72) 66 (59–70) 65 (57–70) n.s. n.s. p = 0.022 p = 0.022
Gender (M/F) 205/75 135/37
Body mass index
(kg/m2)
24 (26–29) 26 (27–29) 28 (25–30) 28 (25–31) n.s. n.s. p = 0.006 p = 0.006
Systolic BP (mm Hg) 117 (127–138) 118 (129–131) 140 (126–150) 140 (126–154) n.s. n.s. p b 0.001 p b 0.001
Diastolic BP (mm Hg) 70 (78–84) 70 (73–83) 80 (70–85) 80 (70–88) n.s. n.s. n.s. n.s.
TC (mg/dl) 187 (215–238) 199 (264–279) 199 (173–227) 206 (178–231) n.s. n.s. p = 0.036 n.s.
TG (mg/dl) 92 (119–178) 134 (153–208) 134 (91–207) 175 (122–257) p = 0.004 p b 0.001 n.s. p b 0.001
HDL-C (mg/dl) 38 (44–53) 40 (50–54) 39 (34–47) 38 (32–47) n.s. n.s. p b 0.001 p = 0.001
LDL-C (mg/dl) 122 (146–170) 132 (190–200) 132 (114–155) 129 (111–153) n.s. n.s. p = 0.009 p = 0.004
RLP-C (mg/dl) 6.5 (5.1–8.5) 8.1 (6.2–11.1) 7.1 (5.7–10.2) 9.3 (7.2–12.8) p b 0.001 p b 0.001 p b 0.05 p b 0.01
RLP-TG (mg/dl) 19.0 (11.7–33.2) 48.4 (25.4–64.4) 18.4 (12.3–35.7) 42.8 (20.6–75.6) p b 0.001 p b 0.001 n.s. n.s.
RLP-TG/RLP-C 2.9 (2.0–3.6) 6 (2.4–4.7) 2.6 (2.1–3.8) 4.6 (2.7–6.3) p b 0.001 p b 0.001 n.s. p = 0.001
RLP-TG/TG 0.16 (0.13–0.20) 0.21 (0.16–0.28) 0.15 (0.12–0.2) 0.24 (0.17–0.33) p b 0.001 p b 0.001 n.s. p = 0.012
Glucose (mg/dl) 86 (93–100) 82 (88–99) 105 (95–131) 101 (90–139) n.s. n.s. p b 0.001 p b 0.001
Insulin (μU/ml) 7 (9–13) 7 (13−21) 13 (9–23) 11 (9–13) n.s. n.s. p b 0.001 n.s.
49K. Nakajima et al. / Clinica Chimica Acta 465 (2017) 45–52and postprandial states [32]. Furthermore, one ﬁfth of the total TG is
used clinically as VLDL-C concentration. However, VLDL-C and TG
have not been recognized as a well-established CHD independent risk
factor because of themany inconsistent results obtained among various
clinical studies, particularly in the fasting plasma.
The postprandial TG increase has long known as to RLP increase in
plasma [1]. However, increase of RLP in the postprandial plasma has
not been clearly shown by ultracentrifugation separation (IDL) or
other methods [13–15]. Using RLP isolation method, we reported the
differences between increased ratio of TG or VLDL and of RLP in both
the fasting and postprandial plasma [21]. Although the cholesterol con-
tent in RLP (RLP-C) is commonly found to be b10% of TC even in the
postprandial plasma, TG in remnant lipoproteins (RLP-TG) is found to
beN20% in the fastingplasma TGand asmuch as 50% in the postprandial
plasma TG under various conditions. We have shown in this study that
signiﬁcantly higher RLP-TG is contained in the postprandial plasma than
fasting plasmawhen the TG concentration is adjusted as the RLP-TG/TG
ratio (concentration) in healthy controls and CAD cases (Fig. 6). These
results show clearly that the amount and ratio of RLP in the postprandial
TG increased signiﬁcantly compared with the fasting plasma TG. In par-
ticular, the increase in the postprandial delta RLP-TG concentration con-
tributed to approximately 50–60% of the increase in the postprandial
delta TG after typical moderate meal intake. However, N80% of the in-
creased delta TG was comprised of delta RLP-TG after fat load or fat
richmeal. These results clearly show that the kind of foods as contained
in a fat rich meal greatly enhance the formation of RLP in the postpran-
dial plasma comparedwith a typicalmoderatemeal.Marcoux et al. [33],Fig. 4. The correlation in controls between plasma TG and RLP-TG in the fastinOoi et al. [9] and Nakajima et al. [34] previously reported similar results
in small number of Caucasian and Japanese healthy volunteers, in
whom approximately 60–80% of the delta RLP-TG in delta TGs were
found 3–6 h after a fat rich meal. The rest of the increased TG consisted
of increased non-RLP-VLDL-TG, LDL-TG and HDL-TG in the postprandial
plasma.
The postprandial RLP contained both apoB-48 and apoB-100 carry-
ing particles [21,35,36]. The increase in the number of RLP apoB-100
particles (VLDL remnants) in fact was greater than that of apoB-48 con-
taining lipoproteins (CM remnants) in the postprandial state. Of note,
the accumulation of large TRL apoB-100 particles seems to be a particu-
lar characteristic of hypertriglyceridemic patients with coronary heart
disease (CHD) compared with healthy hypertriglyceridemic subjects,
suggesting a link between the accumulation of large VLDL and the de-
velopment of atherosclerosis [37].
The Framingham Offspring Study have reported the differences in
clinical signiﬁcance between TG and RLP in the fasting state [5,38,39].
Namely, the fasting RLP-C concentration was shown to be signiﬁcantly
more predictive of cardiovascular events than the fasting TG concentra-
tion. Those studies suggest that when samples are collected in the
fasting state, RLP-C determination may be needed in addition to the
TG concentration. Although RLP-TG in CAD patients was not shown to
be signiﬁcantly increased compared with that of normal controls in
Table 3, the RLP-C concentration in CAD was signiﬁcantly increased
comparedwith that of normal controls in both the fasting and postpran-
dial plasma. This result may be inﬂuenced by the effect of heparin ad-
ministration on the decrease of RLP-TG at the time of bloodg and random (postprandial) plasma and between delta TG and RLP-TG.
Fig. 5. The correlation in CAD patients between plasma TG and RLP-TG in the fasting and random (postprandial) plasma and between delta TG and RLP-TG.
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C, as shown by Sato et al. [22]. These results suggest that postprandial
RLP with large particle size was more strongly associated with cardio-
vascular risk than fasting RLP with small particle size. These ﬁndings
suggest the same conclusion as in recent population studies [2–4],
that the TG concentration measured in fasting samples is less sensitive
than the non-fasting TG in predicting the risk of cardiovascular events.
Given the high correlations between the postprandial RLP-TG and post-
prandial total TG concentrationswe demonstrated, themeasurement of
the postprandial TG concentration may obviate the need for measuring
RLP-TG in routine clinical practice.
The reason why RLP-TG increased in plasma after food intake is ap-
parently associatedwith LPL activity and concentration. Formany years,
it has been believed that LPL activity in plasma increases after food in-
take in order to enhance the postprandial lipid metabolism of
overloaded CM and VLDL, but we recently reported that LPL did not sig-
niﬁcantly increase after any kind of food intake [40]. RLP-TG increase
means not only an increase in the TG concentration in RLP particle,
but also an increase in the particle size, as shown by the increased
RLP-TG/RLP-C ratio after food intake [41,42]. A signiﬁcant increase inFig. 6. RLP-TG/TG ratio in the fasting and postprandial plasma in healthy volunteerthe RLP-TG/RLP-C ratio was always found in the postprandial plasma
after a fat load (Table 1) or typical food intake (Tables 2 and 3) in both
normal subjects and CAD patients. When LPL activity is not sufﬁcient
to hydrolyze overloaded CM or VLDL on the endothelium, less efﬁcient
hydrolysis may occur and enhance the formation of less metabolized
RLP particles along with the higher RLP-TG/RLP-C ratio. Those RLP par-
ticles carry a signiﬁcantly lower LPL per particle compared to small
RLP particles, as shown by the LPL/RLP-TG ratio (Tables 1 and 2). Be-
cause unchanged number of LPL after food intake have to reactwith sig-
niﬁcantly increased CM and VLDL particles on the endothelium.
Therefore, when the LPL activity and concentration are not enough to
hydrolyze the excessive amount of TG-rich lipoproteins, large size RLP
particles are formed on the endothelium and released into the circula-
tion in the postprandial plasma.
As majority of LPL is bound to RLP in pre-heparin plasma, LPL could
be a ligand for remnant receptors in liver and muscles [43–45]. Also
more clearly, we can express the interaction correlation between TG
content and LPL activity in RLP particles as LPL/RLP-TG ratio. For exam-
ple, LPL concentration in RLP increased signiﬁcantly after heparin ad-
ministration and RLP-TG decreased signiﬁcantly as the result of itss (A), CAD and controls in the fasting and random (postprandial) plasma (B).
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LPL/RLP-TG ratio. As postprandial large RLP particles showed approxi-
mately 1/4 of LPL/RLPTG ratio compared to fasting small RLP particles
(Tables 1 and 2), the function of LPL as a ligand for the receptor binding
may become less effective for the clearance of remnants and accumulate
more in plasma. Therefore, high RLP-C and RLP-TC concentration in pa-
tients with cardiovascular disease and diabetes are known to be associ-
ated with the delayed clearance of RLP [46,47].
As RLP is known to be cleared by LRP and VLDL receptors in liver and
muscle, those interactions may be controlled by LPL concentration in
RLP as a ligand to the receptors [48,49]. Those results suggest that the
large RLP particles with small amount of LPL in the postprandial plasma
is a higher risk factor for cardiovascular disease, as shown previous re-
ports [37,47,50].
In summary, these results support the previous studies that showed
the non-fasting TG concentrations to be stronger predictor for the risk of
CVD than fasting TG, because of the higher concentration of a larger
sized RLP particles expressed as higher RLP-TG along with a small
amount of LPL in the postprandial plasma compared to the fasting plas-
ma. Therefore, non-fasting TG measurements performed 3–6 h after
food intake may be able to take the place of the direct measurement
of RLP-TG for the assessment of cardiovascular disease risk.
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